{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T14:19:47Z","timestamp":1790000387319,"version":"4.0.1"},"reference-count":69,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T00:00:00Z","timestamp":1777420800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000780","name":"European Commission","doi-asserted-by":"publisher","award":["E63C25000640004"],"award-info":[{"award-number":["E63C25000640004"]}],"id":[{"id":"10.13039\/501100000780","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000780","name":"European Commission","doi-asserted-by":"publisher","award":["E63C22000940007"],"award-info":[{"award-number":["E63C22000940007"]}],"id":[{"id":"10.13039\/501100000780","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000780","name":"European Commission","doi-asserted-by":"publisher","award":["E53D23009940006"],"award-info":[{"award-number":["E53D23009940006"]}],"id":[{"id":"10.13039\/501100000780","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Biological Macromolecules"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1016\/j.ijbiomac.2026.152317","type":"journal-article","created":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T16:27:09Z","timestamp":1777480029000},"page":"152317","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Modulating STAT3 pathway in breast cancer: Improved activity of T40214 aptamer by peptide-based nanofibers delivering"],"prefix":"10.1016","volume":"364","author":[{"given":"Rosa","family":"Bellavita","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniela","family":"Benigno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marialuisa","family":"Piccolo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simone","family":"Braccia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carla","family":"Aliberti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Federica","family":"Iazzetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonella","family":"Virgilio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Veronica","family":"Esposito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Federica","family":"Donadio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emanuela","family":"Esposito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Giordano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annarita","family":"Falanga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlo","family":"Irace","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aldo","family":"Galeone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefania","family":"Galdiero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijbiomac.2026.152317_bb0005","doi-asserted-by":"crossref","first-page":"3781","DOI":"10.3390\/molecules24203781","article-title":"G-Quadruplex-Forming Aptamers-Characteristics, Applications, and Perspectives","volume":"24","author":"Roxo","year":"2019","journal-title":"Molecules"},{"key":"10.1016\/j.ijbiomac.2026.152317_bb0010","doi-asserted-by":"crossref","DOI":"10.1038\/mtna.2014.32","article-title":"Oligonucleotide aptamers: new tools for targeted cancer therapy","volume":"3","author":"Sun","year":"2014","journal-title":"Mol. Ther. Nucleic. Acids."},{"key":"10.1016\/j.ijbiomac.2026.152317_bb0015","doi-asserted-by":"crossref","first-page":"gkaf424","DOI":"10.1093\/nar\/gkaf424","article-title":"Analysis of quadruplex propensity of aptamer sequences, Nucleic","volume":"53","author":"Cucchiarini","year":"2025","journal-title":"Acids. Res."},{"key":"10.1016\/j.ijbiomac.2026.152317_bb0020","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijbiomac.2025.139896","article-title":"Identification of G-quadruplex nucleic acid structures by high-throughput sequencing: A review","volume":"297","author":"Song","year":"2025","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.ijbiomac.2026.152317_bb0025","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.2174\/092986709787846640","article-title":"Nucleic acid aptamers based on the G-quadruplex structure: therapeutic and diagnostic potential","volume":"16","author":"Gatto","year":"2009","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.ijbiomac.2026.152317_bb0030","doi-asserted-by":"crossref","DOI":"10.1016\/j.ab.2025.115844","article-title":"Recent advancements in aptamers as promising nanotool for therapeutic and diagnostic applications","volume":"702","author":"Alsaidan","year":"2025","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.ijbiomac.2026.152317_bb0035","doi-asserted-by":"crossref","first-page":"6742","DOI":"10.3390\/ijms25126742","article-title":"Therapeutic Applications of Aptamers","volume":"25","author":"Santarpia","year":"2024","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ijbiomac.2026.152317_bb0040","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1007\/s11010-022-04614-x","article-title":"Development and classification of RNA aptamers for therapeutic purposes: an updated review with emphasis on cancer","volume":"478","author":"Razlansari","year":"2023","journal-title":"Mol. Cell. Biochem."},{"key":"10.1016\/j.ijbiomac.2026.152317_bb0045","doi-asserted-by":"crossref","first-page":"1217769","DOI":"10.3389\/fmolb.2023.1217769","article-title":"Anti-nucleolin aptamer AS1411: an advancing therapeutic","volume":"10","author":"Van den Avont","year":"2023","journal-title":"Front. Mol. Biosci."},{"key":"10.1016\/j.ijbiomac.2026.152317_bb0050","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1002\/med.21737","article-title":"Anti-VEGF DNA-based aptamers in cancer therapeutics and diagnostics","volume":"41","author":"Riccardi","year":"2021","journal-title":"Med. Res. Rev."},{"key":"10.1016\/j.ijbiomac.2026.152317_bb0055","doi-asserted-by":"crossref","first-page":"9524","DOI":"10.3390\/ijms24119524","article-title":"Structural and Biological Features of G-Quadruplex Aptamers as Promising Inhibitors of the STAT3 Signaling Pathway","volume":"24","author":"Esposito","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ijbiomac.2026.152317_bb0060","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1038\/nrc1275","article-title":"The STATs of cancer--new molecular targets come of age","volume":"4","author":"Yu","year":"2004","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.ijbiomac.2026.152317_bb0065","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbcan.2025.189461","article-title":"STAT3 axis in cancer and cancer stem cells: From oncogenesis to targeted therapies","volume":"1880","author":"Godugu","year":"2025","journal-title":"Biochim. Biophys. Acta Rev. Cancer"},{"key":"10.1016\/j.ijbiomac.2026.152317_bb0070","doi-asserted-by":"crossref","DOI":"10.1016\/j.cyto.2024.156766","article-title":"Synthetic trimeric interleukin-6 receptor complexes with a STAT3 phosphorylation dominated activation profile","volume":"184","author":"Seibel","year":"2024","journal-title":"Cytokine"},{"key":"10.1016\/j.ijbiomac.2026.152317_bb0075","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1038\/s41577-018-0066-7","article-title":"Recent insights into targeting the IL-6 cytokine family in inflammatory diseases and cancer","volume":"18","author":"Jones","year":"2018","journal-title":"Nat. Rev. Immunol."},{"issue":"2020","key":"10.1016\/j.ijbiomac.2026.152317_bb0080","article-title":"STAT3 signaling pathway in health and disease","volume":"6","author":"Samad","year":"2025","journal-title":"MedComm"},{"key":"10.1016\/j.ijbiomac.2026.152317_bb0085","first-page":"2585","article-title":"Overview of the STAT-3 signaling pathway in cancer and the development of specific inhibitors","volume":"19","author":"Gu","year":"2020","journal-title":"Oncol. Lett."},{"key":"10.1016\/j.ijbiomac.2026.152317_bb0090","doi-asserted-by":"crossref","first-page":"897","DOI":"10.3390\/cancers6020897","article-title":"STAT3 Target Genes Relevant to Human Cancers","volume":"6","author":"Carpenter","year":"2014","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.ijbiomac.2026.152317_bb0095","doi-asserted-by":"crossref","first-page":"2393","DOI":"10.1002\/cncr.10499","article-title":"Activation of Stat-3 as one of the early events in tobacco chewing-mediated oral carcinogenesis","volume":"94","author":"Nagpal","year":"2002","journal-title":"Cancer"},{"key":"10.1016\/j.ijbiomac.2026.152317_bb0100","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.oraloncology.2015.11.022","article-title":"The STAT3 pathway as a therapeutic target in head and neck cancer: Barriers and innovations","volume":"56","author":"Geiger","year":"2016","journal-title":"Oral Oncol."},{"key":"10.1016\/j.ijbiomac.2026.152317_bb0105","article-title":"Role of STAT3 in lung cancer","volume":"3","author":"Dutta","year":"2014","journal-title":"JAKSTAT"},{"key":"10.1016\/j.ijbiomac.2026.152317_bb0110","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1186\/s12964-020-0527-z","article-title":"Role of STAT3 signaling pathway in breast cancer","volume":"18","author":"Ma","year":"2020","journal-title":"Cell Commun. Signal"},{"key":"10.1016\/j.ijbiomac.2026.152317_bb0115","doi-asserted-by":"crossref","first-page":"603","DOI":"10.3390\/ijms22020603","article-title":"The Multifaced Role of STAT3 in Cancer and Its Implication for Anticancer Therapy","volume":"22","author":"Tolomeo","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ijbiomac.2026.152317_bb0120","doi-asserted-by":"crossref","first-page":"6613","DOI":"10.1038\/sj.onc.1204086","article-title":"STAT proteins: novel molecular targets for cancer drug discovery","volume":"19","author":"Turkson","year":"2000","journal-title":"Oncogene"},{"key":"10.1016\/j.ijbiomac.2026.152317_bb0125","doi-asserted-by":"crossref","first-page":"10151","DOI":"10.1073\/pnas.0604042103","article-title":"STAT3: a multifaceted oncogene","volume":"103","author":"Levy","year":"2006","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ijbiomac.2026.152317_bb0130","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/s13046-024-02949-5","article-title":"Unraveling the complexity of STAT3 in cancer: molecular understanding and drug discovery","volume":"43","author":"Hu","year":"2024","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.ijbiomac.2026.152317_bb0135","doi-asserted-by":"crossref","first-page":"5952","DOI":"10.3390\/ijms23115952","article-title":"Antiproliferative Effects of the Aptamer d(GGGT)(4) and Its Analogues with an Abasic-Site Mimic Loop on Different Cancer Cells","volume":"23","author":"Virgilio","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ijbiomac.2026.152317_bb0140","doi-asserted-by":"crossref","first-page":"9448","DOI":"10.1093\/nar\/gkr539","article-title":"Stacking of G-quadruplexes: NMR structure of a G-rich oligonucleotide with potential anti-HIV and anticancer activity","volume":"39","author":"Do","year":"2011","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.ijbiomac.2026.152317_bb0145","doi-asserted-by":"crossref","first-page":"753","DOI":"10.3390\/biom15060753","article-title":"Effects of 5-Methyl-2'-Deoxycytidine in G-Quadruplex Forming Aptamers d(G(3)C)(4) and d[GCG(2)(CG(3))(3)C]: Investigating the Key Role of the Loops","volume":"15","author":"Esposito","year":"2025","journal-title":"Biomolecules"},{"key":"10.1016\/j.ijbiomac.2026.152317_bb0150","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2022.114168","article-title":"STAT3 signaling in prostate cancer progression and therapy resistance: An oncogenic pathway with diverse functions","volume":"158","author":"Sadrkhanloo","year":"2023","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.ijbiomac.2026.152317_bb0155","doi-asserted-by":"crossref","first-page":"1430","DOI":"10.1002\/pros.20807","article-title":"T40214\/PEI complex: a potent therapeutics for prostate cancer that targets STAT3 signaling","volume":"68","author":"Weerasinghe","year":"2008","journal-title":"Prostate"},{"key":"10.1016\/j.ijbiomac.2026.152317_bb0160","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1038\/nrd.2016.199","article-title":"Aptamers as targeted therapeutics: current potential and challenges","volume":"16","author":"Zhou","year":"2017","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.ijbiomac.2026.152317_bb0165","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1039\/D1TB02098F","article-title":"Aptamers: an emerging navigation tool of therapeutic agents for targeted cancer therapy","volume":"10","author":"Yang","year":"2021","journal-title":"J. Mater. Chem. B"},{"key":"10.1016\/j.ijbiomac.2026.152317_bb0170","doi-asserted-by":"crossref","DOI":"10.1002\/open.202400463","article-title":"Progress in Aptamer Research and Future Applications","volume":"14","author":"Liu","year":"2025","journal-title":"ChemistryOpen"},{"key":"10.1016\/j.ijbiomac.2026.152317_bb0175","doi-asserted-by":"crossref","DOI":"10.1016\/j.cbpa.2024.102506","article-title":"Strategies and mechanisms for endosomal escape of therapeutic nucleic acids","volume":"81","author":"Grau","year":"2024","journal-title":"Curr. Opin. Chem. Biol."},{"key":"10.1016\/j.ijbiomac.2026.152317_bb0180","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejpb.2024.114354","article-title":"Aptamer-Drug conjugates for a targeted and synergistic anticancer Response: Exploiting T30923-5-fluoro-2'-deoxyuridine (INT-FdU) derivatives","volume":"201","author":"Benigno","year":"2024","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.ijbiomac.2026.152317_bb0185","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.addr.2018.08.005","article-title":"Aptamer-based targeted therapy","volume":"134","author":"Zhu","year":"2018","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.ijbiomac.2026.152317_bb0190","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.jconrel.2020.03.040","article-title":"Nucleic acid-based drug delivery strategies","volume":"323","author":"Tan","year":"2020","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ijbiomac.2026.152317_bb0195","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1038\/s41392-024-02112-8","article-title":"Landscape of small nucleic acid therapeutics: moving from the bench to the clinic as next-generation medicines","volume":"10","author":"Liu","year":"2025","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.ijbiomac.2026.152317_bb0200","doi-asserted-by":"crossref","first-page":"2352","DOI":"10.1002\/smll.201403073","article-title":"Aptamers and their applications in nanomedicine","volume":"11","author":"Sun","year":"2015","journal-title":"Small"},{"key":"10.1016\/j.ijbiomac.2026.152317_bb0205","doi-asserted-by":"crossref","first-page":"830","DOI":"10.3390\/molecules23040830","article-title":"Applications of Cancer Cell-Specific Aptamers in Targeted Delivery of Anticancer Therapeutic Agents","volume":"23","author":"Kim","year":"2018","journal-title":"Molecules"},{"key":"10.1016\/j.ijbiomac.2026.152317_bb0210","doi-asserted-by":"crossref","first-page":"14475","DOI":"10.3390\/ijms232214475","article-title":"Advances in Aptamers-Based Applications in Breast Cancer: Drug Delivery, Therapeutics, and Diagnostics","volume":"23","author":"Gholikhani","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ijbiomac.2026.152317_bb0215","doi-asserted-by":"crossref","first-page":"9123","DOI":"10.3390\/ijms21239123","article-title":"Aptamer-Functionalized Nanoparticles in Targeted Delivery and Cancer Therapy","volume":"21","author":"Fu","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ijbiomac.2026.152317_bb0220","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijbiomac.2023.124103","article-title":"Biomedical applications of aptamer-modified chitosan nanomaterials: An updated review","volume":"238","author":"Fathi-Karkan","year":"2023","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.ijbiomac.2026.152317_bb0225","doi-asserted-by":"crossref","DOI":"10.1002\/psc.3558","article-title":"Hydrophobicity: The door to drug delivery","volume":"30","author":"Falanga","year":"2024","journal-title":"J. Pept. Sci."},{"key":"10.1016\/j.ijbiomac.2026.152317_bb0230","doi-asserted-by":"crossref","DOI":"10.1002\/btpr.3366","article-title":"Aptamer-functionalized quantum dots as theranostic nanotools against cancer and bacterial infections: A comprehensive overview of recent trends","volume":"39","author":"Davodabadi","year":"2023","journal-title":"Biotechnol. Prog."},{"key":"10.1016\/j.ijbiomac.2026.152317_bb0235","doi-asserted-by":"crossref","first-page":"3881","DOI":"10.1039\/D3NR05656B","article-title":"Nanotherapeutic approaches for delivery of long non-coding RNAs: an updated review with emphasis on cancer","volume":"16","author":"Davodabadi","year":"2024","journal-title":"Nanoscale"},{"key":"10.1016\/j.ijbiomac.2026.152317_bb0240","first-page":"1973","article-title":"The application of nanoparticles in cancer immunotherapy: Targeting tumor microenvironment","volume":"6","author":"Yang","year":"2021","journal-title":"Bioact. Mater."},{"key":"10.1016\/j.ijbiomac.2026.152317_bb0245","doi-asserted-by":"crossref","first-page":"8608428","DOI":"10.1155\/2023\/8608428","article-title":"An Overview of Supramolecular Platforms Boosting Drug Delivery","volume":"2023","author":"Bellavita","year":"2023","journal-title":"Bioinorg. Chem. Appl."},{"key":"10.1016\/j.ijbiomac.2026.152317_bb0250","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/bip.21328","article-title":"Self-assembly of peptide amphiphiles: from molecules to nanostructures to biomaterials","volume":"94","author":"Cui","year":"2010","journal-title":"Biopolymers"},{"key":"10.1016\/j.ijbiomac.2026.152317_bb0255","doi-asserted-by":"crossref","first-page":"1684","DOI":"10.1126\/science.1063187","article-title":"Self-assembly and mineralization of peptide-amphiphile nanofibers","volume":"294","author":"Hartgerink","year":"2001","journal-title":"Science"},{"key":"10.1016\/j.ijbiomac.2026.152317_bb0260","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2024.124799","article-title":"Effects of nanoparticle size, shape, and zeta potential on drug delivery","volume":"666","author":"Ozturk","year":"2024","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijbiomac.2026.152317_bb0265","doi-asserted-by":"crossref","first-page":"3899","DOI":"10.3390\/nano12213899","article-title":"Surface Functionalization of Nanofibers: The Multifaceted Approach for Advanced Biomedical Applications","volume":"12","author":"Kulkarni","year":"2022","journal-title":"Nanomaterials (Basel)."},{"key":"10.1016\/j.ijbiomac.2026.152317_bb0270","doi-asserted-by":"crossref","first-page":"6057","DOI":"10.2147\/IJN.S453958","article-title":"Tuning Peptide-Based Nanofibers for Achieving Selective Doxorubicin Delivery in Triple-Negative Breast Cancer","volume":"19","author":"Bellavita","year":"2024","journal-title":"Int. J. Nanomedicine"},{"key":"10.1016\/j.ijbiomac.2026.152317_bb0275","doi-asserted-by":"crossref","first-page":"1920","DOI":"10.1021\/acs.molpharmaceut.4c01125","article-title":"Engineering Multifunctional Peptide-Decorated Nanofibers for Targeted Delivery of Temozolomide across the Blood-Brain Barrier","volume":"22","author":"Bellavita","year":"2025","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.ijbiomac.2026.152317_bb0280","doi-asserted-by":"crossref","first-page":"1544","DOI":"10.3390\/pharmaceutics14081544","article-title":"Design and Validation of Nanofibers Made of Self-Assembled Peptides to Become Multifunctional Stimuli-Sensitive Nanovectors of Anticancer Drug Doxorubicin","volume":"14","author":"Del Genio","year":"2022","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.ijbiomac.2026.152317_bb0285","doi-asserted-by":"crossref","DOI":"10.3389\/fphys.2022.932099","article-title":"gH625-liposomes deliver PACAP through a dynamic in vitro model of the blood-brain barrier","volume":"13","author":"Barra","year":"2022","journal-title":"Front. Physiol."},{"issue":"1 Pt A","key":"10.1016\/j.ijbiomac.2026.152317_bb0290","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.bbamem.2014.10.006","article-title":"Galdiero, gH625: a milestone in understanding the many roles of membranotropic peptides","volume":"1848","author":"Galdiero","year":"2015","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.ijbiomac.2026.152317_bb0295","doi-asserted-by":"crossref","first-page":"2723","DOI":"10.1038\/s41598-019-38574-y","article-title":"Small Peptide Ligands for Targeting EGFR in Triple Negative Breast Cancer Cells","volume":"9","author":"Hossein-Nejad-Ariani","year":"2019","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ijbiomac.2026.152317_bb0300","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1016\/j.omtn.2019.10.013","article-title":"Size Matters: Arginine-Derived Peptides Targeting the PSMA Receptor Can Efficiently Complex but Not Transfect siRNA","volume":"18","author":"Cultrara","year":"2019","journal-title":"Mol. Ther. Nucleic. Acids."},{"key":"10.1016\/j.ijbiomac.2026.152317_bb0305","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijbiomac.2024.139219","article-title":"Shielding siRNA by peptide-based nanofibers: An efficient approach for turning off EGFR gene in breast cancer","volume":"292","author":"Bellavita","year":"2025","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.ijbiomac.2026.152317_bb0310","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.3390\/antibiotics11101285","article-title":"Synthetic Amphipathic beta-Sheet Temporin-Derived Peptide with Dual Antibacterial and Anti-Inflammatory Activities","volume":"11","author":"Bellavita","year":"2022","journal-title":"Antibiotics (Basel)."},{"key":"10.1016\/j.ijbiomac.2026.152317_bb0315","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1136\/ard-2023-224479","article-title":"New biologic (Ab-IPL-IL-17) for IL-17-mediated diseases: identification of the bioactive sequence (nIL-17) for IL-17A\/F function","volume":"82","author":"Saviano","year":"2023","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.ijbiomac.2026.152317_bb0320","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1021\/acsomega.8b02503","article-title":"Aggregation of Nile Red in Water: Prevention through Encapsulation in beta-Cyclodextrin","volume":"4","author":"Ray","year":"2019","journal-title":"ACS Omega"},{"key":"10.1016\/j.ijbiomac.2026.152317_bb0325","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1080\/14756366.2022.2134359","article-title":"Unveiling the mechanism of action of acylated temporin L analogues against multidrug-resistant Candida albicans","volume":"38","author":"Bellavita","year":"2023","journal-title":"J. Enzyme. Inhib. Med. Chem."},{"key":"10.1016\/j.ijbiomac.2026.152317_bb0330","doi-asserted-by":"crossref","first-page":"918","DOI":"10.3390\/pharmaceutics17070918","article-title":"Ferroptosis Among the Antiproliferative Pathways Activated by a Lipophilic Ruthenium(III) Complex as a Candidate Drug for Triple-Negative Breast Cancer","volume":"17","author":"Ferraro","year":"2025","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.ijbiomac.2026.152317_bb0335","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1021\/acs.jmedchem.4c01665","article-title":"Design, Synthesis, and Anticancer Activity of Drug-like Iron Chelators\/G-Quadruplex Binders as Synergic Dual Targeting Agents","volume":"68","author":"Piccolo","year":"2025","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ijbiomac.2026.152317_bb0340","doi-asserted-by":"crossref","DOI":"10.1093\/nar\/gku111","article-title":"Thioflavin T as a fluorescence light-up probe for G4 formation","volume":"42","author":"Renaud de la Faverie","year":"2014","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.ijbiomac.2026.152317_bb0345","doi-asserted-by":"crossref","DOI":"10.1016\/j.drup.2021.100769","article-title":"The role of endolysosomal trafficking in anticancer drug resistance","volume":"57","author":"Hussein","year":"2021","journal-title":"Drug Resist. Updat."}],"container-title":["International Journal of Biological Macromolecules"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0141813026022440?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0141813026022440?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T13:52:27Z","timestamp":1789998747000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0141813026022440"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":69,"alternative-id":["S0141813026022440"],"URL":"https:\/\/doi.org\/10.1016\/j.ijbiomac.2026.152317","relation":{},"ISSN":["0141-8130"],"issn-type":[{"value":"0141-8130","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Modulating STAT3 pathway in breast cancer: Improved activity of T40214 aptamer by peptide-based nanofibers delivering","name":"articletitle","label":"Article Title"},{"value":"International Journal of Biological Macromolecules","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijbiomac.2026.152317","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"152317"}}